Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Oxylabs

Explore full profile

Web data and proxy infrastructure for AI agents and enterprise intelligence

Vilnius, LithuaniaFounded 2015AI
Valuation $2.5–5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Oxylabs and the history behind them.

About Oxylabs

Oxylabs is a Vilnius-based web data and proxy infrastructure platform founded in 2015 that enables companies to gather public web data at scale for AI, e-commerce, market research and enterprise use cases. The company evolved from a premium proxy network into full-stack web-intelligence infrastructure for agents and models, with ethical IP procurement and GDPR/CCPA-oriented compliance; it reports serving hundreds of thousands of customers and about €305.8 million ($350 million) ARR. In July 2026 Oxylabs secured €113.6 million ($130 million) from Warburg Pincus Capital Solutions Founders Fund at a €3.1 billion ($3.6 billion) valuation—its first external institutional round after years of bootstrapping via Tesonet—to accelerate agentic web-search infrastructure, product development and M&A after prior acquisitions of Webshare and ScrapingBee. Sources: EU-Startups 10 Jul 2026; company.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Vilnius, Lithuania
Employees
492
Open positions
52
Dealroom signal
89.9/100
Sector
AI, Market Intelligence, SEO, Data Provider, Core AI, Big Data and Analytics, Data Storage, StartupLithuania, Verified Unicorns and $1B Exits, MLops, AI Data Preparation and Generation
Technology
Artificial Intelligence, Big Data
Business model
SaaS
Client focus
b2b
Investment activity
3 companies, latest Oct 2025
Capital deployed
$2K
Preferred round
ACQUISITION

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Jul 2026 $130M $3.6B Warburg Pincus ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Oxylabs website traffic

Latest recorded traffic for Oxylabs is 530K monthly website visits, up 3.9% over the last three months. Oxylabs's team grew 36.7% over the past year.

Latest monthly visits530K 3-month web change+3.9% 1-year team growth+36.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇱🇹 Lithuania · Vilnius HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Oxylabs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oxylabs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.